Replies to post #98167 on Biotech Values

[turtlepower]

The difference in disease progression between placebo and provenge was only 0.2 weeks favoring provenge so patients would likely be reintroduced to chemo and the total cost would be provenge + chemo. So it would appear that the total cost when treating a patient with provenge would be higher especially since the patient lives longer after disease progresses.

[rkrw]

Do companies exaggerate the cost of supportive care to make their case?